Next, to investigate whether malignant cells acquire an increased capacity to produce IL-10 at progression and, therefore, higher plasmatic levels are not simply reflecting the higher tumoral load at progression, we assessed the production of IL-10 by CLL cells in vitro after microenvironmental stimuli [27]. Here, IL10 is linked to B-cell chronic lymphocytic leukemia.